DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,258 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,963 | +49.9% | 14,402 | +37.1% | 0.24% | +26.7% |
Q1 2024 | $2,643 | -99.9% | 10,504 | -0.4% | 0.19% | 0.0% |
Q4 2023 | $2,614,000 | -3.8% | 10,547 | +0.9% | 0.19% | -37.0% |
Q2 2022 | $2,718,000 | +5.1% | 10,451 | +23.1% | 0.30% | +17.4% |
Q3 2021 | $2,586,000 | -2.4% | 8,493 | -14.0% | 0.25% | -5.2% |
Q2 2021 | $2,650,000 | +30.7% | 9,875 | +13.1% | 0.27% | +13.6% |
Q1 2021 | $2,028,000 | -0.6% | 8,729 | +1.4% | 0.24% | -5.6% |
Q4 2020 | $2,041,000 | +60.1% | 8,611 | +62.4% | 0.25% | +7.8% |
Q3 2020 | $1,275,000 | +47.2% | 5,303 | +8.5% | 0.23% | +24.9% |
Q2 2020 | $866,000 | +18.8% | 4,888 | +10.6% | 0.18% | +6.3% |
Q1 2020 | $729,000 | +20.7% | 4,419 | +19.6% | 0.17% | +40.3% |
Q4 2019 | $604,000 | +26.1% | 3,695 | +4.2% | 0.12% | +17.0% |
Q3 2019 | $479,000 | +10.9% | 3,545 | +16.1% | 0.11% | +5.0% |
Q2 2019 | $432,000 | +9.9% | 3,053 | +1.5% | 0.10% | +5.2% |
Q1 2019 | $393,000 | +14.9% | 3,007 | -2.3% | 0.10% | +5.5% |
Q4 2018 | $342,000 | +19.6% | 3,078 | +6.2% | 0.09% | +16.7% |
Q3 2018 | $286,000 | +0.4% | 2,899 | +2.2% | 0.08% | +1.3% |
Q2 2018 | $285,000 | -12.0% | 2,836 | -9.9% | 0.08% | -13.5% |
Q1 2018 | $324,000 | +11.0% | 3,146 | +2.2% | 0.09% | +6.0% |
Q4 2017 | $292,000 | +9.0% | 3,078 | +6.3% | 0.08% | +1.2% |
Q3 2017 | $268,000 | +8.9% | 2,896 | -4.8% | 0.08% | +5.1% |
Q2 2017 | $246,000 | 0.0% | 3,041 | 0.0% | 0.08% | 0.0% |
Q1 2017 | $246,000 | +8.8% | 3,041 | +17.2% | 0.08% | +8.2% |
Q4 2016 | $226,000 | +39.5% | 2,594 | +54.6% | 0.07% | -26.3% |
Q1 2016 | $162,000 | – | 1,678 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |